Nuveen Asset Management, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$1,261
-80.1%
792,772
-22.2%
0.00%
-100.0%
Q4 2022$6,349
-99.7%
1,019,196
+238.2%
0.00%
+100.0%
Q3 2022$2,019,000
+62.8%
301,359
+54.6%
0.00%
Q2 2022$1,240,000
-34.2%
194,967
-42.8%
0.00%
-100.0%
Q1 2022$1,885,000
+377.2%
340,899
+330.8%
0.00%
Q4 2021$395,000
-67.8%
79,127
-19.4%
0.00%
Q3 2021$1,226,000
-65.1%
98,114
-40.9%
0.00%
-100.0%
Q2 2021$3,511,000
-41.6%
165,998
-22.5%
0.00%
-50.0%
Q1 2021$6,007,000
+95.4%
214,134
+81.1%
0.00%
+100.0%
Q4 2020$3,074,000
-34.5%
118,215
-6.4%
0.00%
-50.0%
Q3 2020$4,696,000
-44.6%
126,359
-23.5%
0.00%
-33.3%
Q2 2020$8,473,000
+45.8%
165,126
-10.4%
0.00%0.0%
Q1 2020$5,813,000
-40.6%
184,347
+12.4%
0.00%
-25.0%
Q4 2019$9,778,000
-7.9%
163,976
-43.4%
0.00%0.0%
Q3 2019$10,620,000
-40.7%
289,676
-24.7%
0.00%
-42.9%
Q2 2019$17,898,000384,7440.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2019
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$59,618,00021.09%
Bellevue Group AG 4,519,164$95,580,0000.93%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$36,234,0000.84%
Rhenman & Partners Asset Management AB 572,267$12,103,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 64,434$1,363,0000.45%
Boxer Capital, LLC 500,000$10,575,0000.37%
EMC Capital Management 27,566$583,0000.33%
WASATCH ADVISORS LP 3,766,935$79,671,0000.32%
Avidity Partners Management LP 400,000$8,460,0000.23%
Cinctive Capital Management LP 186,170$3,937,0000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders